Article info
What neurologists need to understand
Homocysteine and methylmalonate: when should I measure them and what do they mean?
- Correspondence to Dr Robin H Lachmann, Charles Dent Metabolic Unit, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK; r.lachmann{at}ucl.ac.uk
Citation
Homocysteine and methylmalonate: when should I measure them and what do they mean?
Publication history
- Accepted February 28, 2016
- First published March 23, 2016.
Online issue publication
July 14, 2016
Article Versions
- Previous version (23 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Homocystinuria diagnosis and management: it is not all classical
- Vitamin B12 deficiency
- Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer’s disease
- Stroke in a young man
- ABC of clinical haematology: Macrocytic anaemias
- A woman with macrocytic anaemia and confusion
- Vitamin B12 and folate deficiency and elevated plasma total homocysteine in workers with chronic exposure to chromate
- B vitamins for stroke prevention
- Nutritional peripheral neuropathies
- Adult-onset methylenetetrahydrofolate reductase deficiency